Strategic partnerships OICR is a not-for-profit research institute actively collaborating with health care providers, government, and the private sector to translate research into clinical practice, presenting opportunities to offer data services, clinical trial support, and commercialization partnerships.

Data and analytics Recent initiatives like the ICGC ARGO data dictionary and cross-disciplinary genomics and informatics work indicate a strong need for secure data sharing, data harmonization, and analytics platforms that can handle large-scale cancer genomics and clinical datasets.

AI and research tools OICR has demonstrated interest in AI-driven solutions for simulated cancer genomes and other advanced analytics, signaling potential for selling AI/ML software, genomic analysis pipelines, and synthetic data capabilities that protect patient confidentiality.

Drug discovery potential OICR is expanding in drug discovery and next generation medicines, including collaborations to develop therapies for aggressive cancers such as medulloblastoma, creating opportunities for assay development, translational research platforms, and early-stage collaboration tools.

Funding and scale With government funding, a multi-million revenue profile, and a mandate to maximize economic benefit for Ontario, there is room for scalable, grant-aligned solutions, training programs, and co-development engagements that align with public funding cycles and performance milestones.